Latest Funding News

Brightstar Resources has released an updated Definitive Feasibility Study for its Goldfields Project, outlining a robust six-year production plan averaging 75,000 ounces of gold annually and a pre-tax NPV of A$606 million. The study highlights a new 1.5Mtpa processing plant with expansion potential and a clear pathway to first gold by mid-2027.

Brightstar Resources has released an updated feasibility study for its Goldfields Project, projecting $1 billion in pre-tax free cash flow and a 74% internal rate of return, setting the stage for a Final Investment Decision in March 2026.

Anson Resources has kicked off a revised drilling program targeting lithium brines in Utah and secured a $14 million capital raise, alongside a key offtake agreement for its Green River Lithium Project.

Prominence Energy has completed its acquisition of the Gawler Natural Hydrogen Project, gaining a significant foothold in Australia's emerging natural hydrogen and helium sector. The company is advancing technical evaluations and preparing for early 2026 field surveys to validate its promising geological prospects.

Mayfield Childcare Limited unveils Mayfield 360, an allied health services division aimed at integrating therapy supports within its childcare network, targeting a sizable and growing segment of the National Disability Insurance Scheme market.

InhaleRx Limited has progressed its clinical trials for three drug candidates targeting cancer pain, panic disorder, and treatment-resistant depression, while securing additional funding and preparing for a company rebrand.

Inhalerx Limited reported a $628,000 cash burn in the December quarter while securing substantial funding facilities to advance its clinical trials. The company’s cash position and financing arrangements suggest a runway extending over 80 quarters at current spending levels.

Red Hill Minerals reported a solid $7.8 million royalty from its Onslow Iron Project and unveiled promising exploration results across its Broken Hill and Anabama projects, reinforcing its growth trajectory.

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.

Pursuit Minerals has voluntarily suspended its shares on the ASX pending the release of a Pre-Feasibility Study and a capital raising announcement, expected imminently.

Australian Critical Minerals has declared its Flint gold-silver project in Peru drill-ready, unveiling a comprehensive technical review and securing permits for an initial diamond drilling program this quarter.

ASF Group Limited closed December 2025 with $1.91 million in cash and nearly four quarters of funding runway, while progressing key investments in mining, technology, and biotech sectors.